References - Therapeutic Strategies in Cancer Biology and Pathology - page 197

Bao, W., Fu, H.J., Xie, Q.S., Wang, L., Zhang, R., Guo, Z.Y., et al., 2011b. HER2 interacts
with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric
cancer cells. Gastroenterol 141, 2076-2100.
Bar, N., Dikstein, R., 2010. MiR-22 forms a regulatory loop in PTEN/AKT pathway and mod-
ulates signaling kinetics. PLoS ONE 5, e10859.
Barbareschi, M., Cuorvo, L.V., Girlando, S., Bragantini, E., Eccher, C., Leonardi, E., et al.,
2012. PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated
with trastuzumab are not related to resistance to anti-Her2 therapy. Virchows Archiv. 461,
129-139.
Baritaki, S., Chapman, A., Yeung, K., Spandidos, D.A., Palladino, M., Bonavida, B., 2009.
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by
the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP
induction. Oncogene 28, 3573-3585.
Barkham, T., Carlsson, B., Nilsson, Y., Enmark, E., Gustafsson, J., Nilsson, S., 1998.
Differential response of estrogen receptor alpha and estrogen receptor beta to partial
estrogen agonists and antagonists. Mol. Pharmacol. 54, 105-112.
Bartel, D.P., 2009. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
Bass, R., Wagstaff, L., Ravenhill, L., Ellis, V., 2009. Binding of extracellular maspin to beta 1
integrins inhibits vascular smooth muscle cell migration. J. Biol. Chem. 284, 27712-27720.
Baumann, P., Cremers, N., Kroese, F., Orend, G., Chiquet-Ehrismann, R., Uede, T., et al.,
2005. CD24 expression causes the acquisition of multiple cellular properties associated
with tumor growth and metastasis. Cancer Res. 65, 10783-10793.
Beach, S., Tang, H., Park, S., Dhillon, A.S., Keller, E.T., Kolch, W., et al., 2008. Snail is
a repressor of RK1P transcription in metastatic prostate cancer cells. Oncogene 27,
2243-2248.
Belshaw, N.J., Elliott, G.O., Foxall, R.J., Dainty, J.R., Pal, N., Coupe, A., et al. 2008. Profiling
CpG island field methylation in both morphologically normal and neoplastic human
colonic mucosa. Br. J. Cancer 99, 136-142.
Benezra, R., 2001. Role of Id proteins in embryonic and tumor angiogenesis. Trends
Cardiovasc Med. 11, 237-241.
Berardi, R., Santinelli, A., Onofri, A., Brunelli, A., Pierantoni, C., Pisa, E., et al., 2012.
Maspin expression is a favorable prognostic factor in non-small cell lung cancer. Anal.
Quant. Cytol. Histol. 34, 72-78.
Bergamaschi, A., Katzenellenbogen, B.S., 2012. Tamoxifen downregulation of miR-451
increases 14-3-3 zeta and promotes breast cancer cell survival and endocrine resistance.
Oncogene 31, 39-47.
Berge, G., Pettersen, S., Grotterod, I., Bettum, I.J., Boye, K., Maelandsmo, G.M., 2011.
Osteopontin - an important downstream effector of S100A4-mediated invasion and
metastasis. Int. J. Cancer 129, 780-790.
Berger, N., Ben Bassat, H., Klein, B.Y., Laskov, R., 2007. Cytotoxicity of NF-kappa B
inhibitors Bay 11-7085 and caffeic acid phenethyl ester to Ramos and other human
B-lymphoma cell lines. Exp. Hematol. 35, 1495-1509.
Berman, D.M., Karhadkar, S.S., Hallahan, A.R., Pritchard, J.I., Eberhart, C.G., Watkins, D.N.,
et al., 2002. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science
297, 1559-1561.
Bernstein, E., Caudy, A.A., Hammond, S.M., Hannon, G.J., 2001. Role for a bidentate ribonu-
clease in the initiation step of RNA interference. Nature 409, 363-366.
Beshir, A.B., Ren, G., Magpusao, A.N., Barone, L.M., Yeung, K.C., Fenteany, G., 2010. Raf
kinase inhibitor protein suppresses nuclear factor-kappa B-dependent cancer cell invasion